Nitric oxide and the endothelium: History and impact on cardiovascular disease
Authors:
- Gunay Yetik-AnacakGYGunay Yetik-Anacak
- John D. CatravasJCJohn D. Catravas
- 1 November 2006
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 45 (5) , 268-276
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Effects of hsp90 binding inhibitors on sGC-mediated vascular relaxationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Racial Variations in Treatment and Outcomes of Black and White Patients With High-Risk Non–ST-Elevation Acute Coronary SyndromesCirculation, 2005
- Heat Shock Protein 90 as an Endogenous Protein Enhancer of Inducible Nitric-oxide SynthaseJournal of Biological Chemistry, 2003
- Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasmHuman Genetics, 2001
- Geldanamycin, an inhibitor of heat shock protein 90 (Hsp90) mediated signal transduction has anti‐inflammatory effects and interacts with glucocorticoid receptor in vivoBritish Journal of Pharmacology, 2000
- Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm. Implication in the pathogenesis of myocardial infarction.Journal of Clinical Investigation, 1995
- Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats.Hypertension, 1993
- Biosynthesis of endothelium-derived relaxing factor: A cytosolic enzyme in porcine aortic endothelial cells Ca2+-dependently converts L-arginine into an activator of soluble guanylyl cyclaseBiochemical and Biophysical Research Communications, 1989
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980